Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Edor Kabashi wins the International Medicine PG Award for Amyotrophic Lateral Sclerosis (ALS) research

Published on: 26/10/2016 Reading time: 1 min
Edor Kabashi

The Paulo Gontijo Institute awarded the International Medicine PG Award to Edor Kabashi, team leader at the Brain and Spine Institute – Institut du Cerveau, for his research on the development of new models and new therapeutic avenues for Amyotrophic Lateral Sclerosis (ALS).

Edor Kabashi joined the Brain and Spine Institute - Institut du Cerveau - ICM in 2011 as the “Treatment of Amyotrophic lateral sclerosis: from genetics to zebrafish” team leader. He obtained his PhD in 2008 at McGill University and did postdoctoral work at Centre of Excellence in Neuromics at University of Montreal. He received many awards, including the Brain Star Award of CIHR Institute of Neuroscience in 2009 and 2011, and the Young investigator award from European Network for the Cure of ALS in 2015.

The International Medicine PG Award is an initiative of the Paulo Gontijo Institute to foster the research of young researchers around the world to promote the cure of ALS.

Selected from 15 studies, Kabashi’s studies have provided a breakthrough in developing new models and therapeutic avenues for Amyotrophic Lateral Sclerosis (ALS).

 

“My team works to better understand how a variety of genetic mutations can cause motor neuron degeneration in ALS. We take advantage of a simple vertebrate model, zebrafish where one or several genes can be manipulated. Using this paradigm, we have described that several major ALS genes interact together and function in common pathways and we are currently identifying drugs which could affect these molecular targets”, says Edor Kabashi.

 

The International Medicine PG Award is recognized by the international scientific community. Its partners the International Alliance of ALS, Motor Neuron Disease Association (MNDA) and the European Community for research for the cure of ALS (ENCALS). The study results will be presented at opening ceremony of the 26th International Symposium on ALS / MND (motor neuron disease) to be held in Dublin (Ireland) in December.

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news